our Premium Content: News alerts, weekly reports and conference planners

TEST:
clonoSEQ

News alerts, weekly reports and conference planners

Company:

Type:

FDA Approved

The clonoSEQ Assay is an in vitro diagnostic that uses multiplex polymerase chain reaction (PCR) and next-generation sequencing (NGS) to identify and quantify rearranged IgH (VDJ), IgH (DJ), IgK, and IgL receptor gene sequences, as well as translocated BCL1/IgH (J) and BCL2/IgH (J) sequences in DNA extracted from bone marrow from patients with B-Cell acute lymphoblastic leukemia (ALL) or multiple myeloma (MM).

Cancer:

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Multiple Myeloma, Non-Hodgkin’s Lymphoma

Gene:

BCL2 (B-cell CLL/lymphoma 2), CCND1 (Cyclin D1)

Method:

Multiplex-PCR / Next-Generation Sequencing (NGS)

Approvals

Date

Cancer

Gene

Biomarker

Drug